Show simple item record

dc.contributor.authorNamazi, H
dc.contributor.authorBelali, S
dc.date.accessioned2018-08-26T07:29:25Z
dc.date.available2018-08-26T07:29:25Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47055
dc.description.abstractIn this paper, a new starch-g-lactic acid/montmorillonite nanocomposite was developed for controlled and sustained drug release. First, starch-g-lactic acid was synthesized by reaction between starch and lactic acid with azeotropic distillation. In order to achieve a high degree of grafting starch, effects of the reaction time and the monomer concentration were evaluated. Bio-based nanocomposites were prepared through solution intercalation technique of starch-g-lactic acid with Closite Na+. The morphology of the samples was evaluated using a scanning electron microscope (SEM) and transmission electron microscopy (TEM). The nanoparticles were spherical with a mean size of around 355 +/- 5 nm. The thermal properties of the nanocomposites were investigated by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). Acetylated starch and its nanoparticle were used to study the overall effect of sustained release of the fluoxetine. The nanocomposite showed good drug encapsulation efficiency and a sustained drug release pattern.
dc.language.isoEnglish
dc.relation.ispartofSTARCH-STARKE
dc.subjectAcetylated starch
dc.subjectControlled release
dc.subjectMontmorillonite
dc.subjectNanocomposite
dc.titleStarch-g-lactic acid/montmorillonite nanocomposite: Synthesis, characterization and controlled drug release study
dc.typeArticle
dc.citation.volume68
dc.citation.issue3-4
dc.citation.spage177
dc.citation.epage187
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1002/star.201400226


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record